Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

NCT01779869 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Heart Disease

Interventions

DRUG: Regadenoson

Sponsor

Washington University School of Medicine

Collaborators

[object Object]